The challenges of oral anticoagulation

Cheryl Nadeau; Bertram Alpert; Thomas Costantino; Regina McGinn; Michael Coyne; Kathleen Ahern; Lodores Hudson; Laura Celardo-Giannone

The challenges of oral anticoagulation

Cheryl Nadeau, Bertram Alpert, Thomas Costantino, Regina McGinn, Michael Coyne, Kathleen Ahern, Lodores Hudson, Laura Celardo-Giannone

Nursing

Research output: Contribution to journal › Article › peer-review

Abstract

Warfarin therapy is underused for stroke prevention in patients with atrial fibrillation. A clearer understanding of warfarin's risk-benefit profile will enable you to prescribe it safely and appropriately.

Original language	English (US)
Pages (from-to)	33-49
Number of pages	17
Journal	Patient Care
Volume	34
Issue number	23
State	Published - 2000

ASJC Scopus subject areas

Leadership and Management

Cite this

@article{fb121be333b04cf6adc3f549dd2e1e55,

title = "The challenges of oral anticoagulation",

abstract = "Warfarin therapy is underused for stroke prevention in patients with atrial fibrillation. A clearer understanding of warfarin's risk-benefit profile will enable you to prescribe it safely and appropriately.",

author = "Cheryl Nadeau and Bertram Alpert and Thomas Costantino and Regina McGinn and Michael Coyne and Kathleen Ahern and Lodores Hudson and Laura Celardo-Giannone",

year = "2000",

language = "English (US)",

volume = "34",

pages = "33--49",

journal = "Patient Care",

issn = "0031-305X",

publisher = "Advanstar Communications Inc.",

number = "23",

}

TY - JOUR

T1 - The challenges of oral anticoagulation

AU - Nadeau, Cheryl

AU - Alpert, Bertram

AU - Costantino, Thomas

AU - McGinn, Regina

AU - Coyne, Michael

AU - Ahern, Kathleen

AU - Hudson, Lodores

AU - Celardo-Giannone, Laura

PY - 2000

Y1 - 2000

N2 - Warfarin therapy is underused for stroke prevention in patients with atrial fibrillation. A clearer understanding of warfarin's risk-benefit profile will enable you to prescribe it safely and appropriately.

AB - Warfarin therapy is underused for stroke prevention in patients with atrial fibrillation. A clearer understanding of warfarin's risk-benefit profile will enable you to prescribe it safely and appropriately.

UR - http://www.scopus.com/inward/record.url?scp=24644473210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644473210&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:24644473210

SN - 0031-305X

VL - 34

SP - 33

EP - 49

JO - Patient Care

JF - Patient Care

IS - 23

ER -

The challenges of oral anticoagulation

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this